Images in Haematology
Bone marrow trephine biopsy appearances of the intravascular subtype of diffuse large B-cell lymphoma
Jennifer J. Thomson, Jon Van Der Walt and Robin Ireland
p.683–683
18F-Fluorodeoxyglucose positron emission tomography for evaluation of intravascular large B-cell lymphoma
Jun Odawara, Noboru Asada, Takatoshi Aoki, Masayuki Yamakura, Masami Takeuchi, Toshihiro Ohuchi and Kosei Matsue
p.684–684
Reviews
Modern management of non-Hodgkin lymphoma in HIV-infected patients
Nicolas Mounier, Michele Spina and Christian Gisselbrecht
p.685–698
Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies
Gadi Lalazar, Deborah Rund and Daniel Shouval
p.699–712
Biomolecular characterisation of leucocytes by infrared spectroscopy
Kan-Zhi Liu, Minqi Xu and David A. Scott
p.713–722
Haematological Maligancy
Charge differences between in vivo deposits in immunoglobulin light chain amyloidosis and non-amyloid light chain deposition disease
Batia Kaplan, Avi Livneh and Gloria Gallo
p.723–728
Technetium-99m sestamibi scintigraphy is sensitive and specific for the staging and the follow-up of patients with multiple myeloma: a multicentre study on 397 scans
Anna Mele, Massimo Offidani, Giuseppe Visani, Monica Marconi, Filippo Cambioli, Marco Nonni, Massimo Catarini, Ernesto Brianzoni, Alfonso Berbellini, Giorgio Ascoli, Marino Brunori, Vanessa Agostini, Laura Corvatta, Alessandro Isidori, Aureliano Spinelli, Marinella Gradari and Pietro Leoni
p.729–735
Phase II study of three dose levels of continuous erythropoietin receptor activator (C.E.R.A.) in anaemic patients with aggressive non-Hodgkin's lymphoma receiving combination chemotherapy
Anders Österborg, Juan Luis Steegmann, Andrzej Hellmann, Stephen Couban, Jiri Mayer and Joseph E. Eid
p.736–744
The JAK2 V617F mutation involves B- and T-lymphocyte lineages in a subgroup of patients with Philadelphia-chromosome negative chronic myeloproliferative disorders
Thomas Stauffer Larsen, Jacob Haaber Christensen, Hans Carl Hasselbalch and Niels Pallisgaard
p.745–751
Ifosphamide, etoposide and epirubicin is an effective combined salvage and peripheral blood stem cell mobilisation regimen for transplant-eligible patients with non-Hodgkin lymphoma and Hodgkin disease
Mark J. Bishton, Richard J. Lush, Jenny L. Byrne, Nigel H. Russell, Bronwen E. Shaw and Andrew P. Haynes
p.752–761
Platelets, Haemostasis and Thrombosis
Higher thrombin concentrations are required to induce platelet apoptosis than to induce platelet activation
V. Leytin, D. J. Allen, E. Lyubimov and J. Freedman
p.762–764
Announcement
Announcement of the 12th Congress Of The European Hematology Association 7–10 June, 2007, Vienna, Austria
p.766–766
|
